Claus Liebmann

1.8k total citations
62 papers, 1.5k citations indexed

About

Claus Liebmann is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Claus Liebmann has authored 62 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 31 papers in Genetics and 13 papers in Oncology. Recurrent topics in Claus Liebmann's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (31 papers), Protein Kinase Regulation and GTPase Signaling (16 papers) and Receptor Mechanisms and Signaling (12 papers). Claus Liebmann is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (31 papers), Protein Kinase Regulation and GTPase Signaling (16 papers) and Receptor Mechanisms and Signaling (12 papers). Claus Liebmann collaborates with scholars based in Germany, France and United States. Claus Liebmann's co-authors include Angela Graneß, Sebastian Drube, Siegmund Reißmann, Peter Presek, Reinhard Wetzker, Christina Valkova, Martin Schnittler, Reinhard Wetzker, Bernd Nürnberg and Klaus Seedorf and has published in prestigious journals such as Journal of Biological Chemistry, Molecular and Cellular Biology and Biochemical Journal.

In The Last Decade

Claus Liebmann

61 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claus Liebmann Germany 21 952 389 300 288 165 62 1.5k
Hartmut Halfter Germany 23 886 0.9× 245 0.6× 255 0.8× 377 1.3× 166 1.0× 36 1.7k
Wilfried Kugler Germany 24 842 0.9× 172 0.4× 146 0.5× 197 0.7× 114 0.7× 40 1.5k
Patrick E. Ward United States 27 747 0.8× 557 1.4× 702 2.3× 621 2.2× 85 0.5× 53 1.7k
Jee‐Yin Ahn South Korea 26 1.2k 1.3× 165 0.4× 237 0.8× 297 1.0× 309 1.9× 77 2.0k
Saya Ito Japan 20 1.4k 1.4× 113 0.3× 384 1.3× 210 0.7× 146 0.9× 62 1.9k
Michael Leserer Germany 4 1.2k 1.2× 92 0.2× 280 0.9× 576 2.0× 176 1.1× 4 1.9k
Reinhard Wetzker Germany 17 2.1k 2.2× 245 0.6× 339 1.1× 397 1.4× 468 2.8× 27 2.8k
Edward V. Wancewicz United States 19 2.1k 2.2× 595 1.5× 498 1.7× 114 0.4× 161 1.0× 25 2.8k
Mohamed Abdouh Canada 28 1.3k 1.4× 275 0.7× 146 0.5× 397 1.4× 182 1.1× 51 1.9k
Eric D. Tomhave United States 18 1.1k 1.2× 328 0.8× 265 0.9× 307 1.1× 749 4.5× 19 2.1k

Countries citing papers authored by Claus Liebmann

Since Specialization
Citations

This map shows the geographic impact of Claus Liebmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claus Liebmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claus Liebmann more than expected).

Fields of papers citing papers by Claus Liebmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claus Liebmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claus Liebmann. The network helps show where Claus Liebmann may publish in the future.

Co-authorship network of co-authors of Claus Liebmann

This figure shows the co-authorship network connecting the top 25 collaborators of Claus Liebmann. A scholar is included among the top collaborators of Claus Liebmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claus Liebmann. Claus Liebmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berndt, Alexander, et al.. (2014). Effects of activated fibroblasts on phenotype modulation, EGFR signalling and cell cycle regulation in OSCC cells. Experimental Cell Research. 322(2). 402–414. 15 indexed citations
2.
Schäfer, Claudia, et al.. (2010). PKCε acts as negative allosteric modulator of EGF receptor signalling. Cellular Signalling. 23(2). 436–448. 6 indexed citations
3.
Drube, Sebastian, et al.. (2006). Ligand-independent and EGF receptor-supported transactivation: Lessons from β2-adrenergic receptor signalling. Cellular Signalling. 18(10). 1633–1646. 52 indexed citations
4.
Valkova, Christina, et al.. (2005). Muscarinic M2 receptors mediate transactivation of EGF receptor through Fyn kinase and without matrix metalloproteases. Cellular Signalling. 18(8). 1338–1349. 22 indexed citations
5.
Liebmann, Claus, et al.. (2002). Intramolecular signal transduction by the bradykinin B2 receptor. International Immunopharmacology. 2(13-14). 1763–1770. 2 indexed citations
6.
7.
Liebmann, Claus. (2001). Bradykinin Signalling to MAP Kinase: Cell-Specific Connections versus Principle Mitogenic Pathways. Biological Chemistry. 382(1). 49–55. 30 indexed citations
8.
Müller, Sylvia, et al.. (2000). Expression and Functional Characterization of a pHis-Tagged Human Bradykinin B2 Receptor in COS-7Cells. Biological Chemistry. 381(4). 343–7. 10 indexed citations
9.
Liebmann, Claus, I. Paegelow, Torsten Steinmetzer, et al.. (2000). Novel non-peptide lead structures for bradykinin B2-receptor antagonists. International Journal of Peptide Research and Therapeutics. 7(2). 69–77. 4 indexed citations
11.
Kaufmann, Roland, Carsten Lindschau, Ae‐Young Her, et al.. (1996). Signaling effects of ?-thrombin and SFLLRN in rat glioma C6 cells. Journal of Neuroscience Research. 46(6). 641–651. 10 indexed citations
12.
Steinmetzer, Torsten, C Schumann, I. Paegelow, et al.. (1995). New Photoaffinity Labelled Agonists of Bradykinin. Biological Chemistry Hoppe-Seyler. 376(1). 25–32. 3 indexed citations
13.
Liebmann, Claus, et al.. (1992). Binding characteristics and functional G protein coupling of muscarinic acetylcholine receptors in rat duodenum smooth muscle membranes. Naunyn-Schmiedeberg s Archives of Pharmacology. 345(1). 7–15. 15 indexed citations
14.
Liebmann, Claus, et al.. (1991). High-affinity bradykinin receptor-catalyzed G protein activation in rat myometrium. European Journal of Pharmacology Molecular Pharmacology. 207(1). 67–71. 11 indexed citations
16.
Liebmann, Claus, Martin Schnittler, John M. Stewart, & Siegmund Reißmann. (1991). Antagonist binding reveals two heterogenous B2 bradykinin receptors in rat myometrial membranes. European Journal of Pharmacology. 199(3). 363–365. 25 indexed citations
17.
Liebmann, Claus, Stefan Offermanns, Karsten Spicher, et al.. (1990). A high-affinity bradykinin receptor in membranes from rat myometrium is coupled to pertussis toxin-sensitive G-proteins of the G i family. Biochemical and Biophysical Research Communications. 167(3). 910–917. 39 indexed citations
18.
Liebmann, Claus, et al.. (1989). Opioid receptor affinities of the blood-derived tetrapeptides hemorphin and cytochrophin. European Journal of Pharmacology. 166(3). 523–526. 46 indexed citations
19.
Liebmann, Claus, et al.. (1978). Effect of bradykinin on prostaglandin synthetase activity in microsomal fractions from rat duodenum and uterus.. PubMed. 37(5-6). 901–3. 2 indexed citations
20.
Roemer, W., et al.. (1978). Effects of prostaglandins, calcium, and bradykinin on guanylate cyclase in different organs.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 37(5-6). 905–6. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026